Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach

Figure 2 Non-alcoholic fatty liver disease and extrahepatic comorbidities (i. e. inflammatory bowel disease, obstructive syndrome apnea and psoriasis) risk phenotypes. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; IBD: Inflammatory bowel disease; NAFLD: Non-alcoholic fatty liver disease; OSA: Obstructive syndrome apnea.